Wordt geladen...
Pituitary adenylate cyclase–activating polypeptide is reduced in Alzheimer disease
OBJECTIVES: There is growing evidence that pituitary adenylate cyclase–activating polypeptide (PACAP) is associated with Alzheimer disease (AD) pathology in animal models, but human studies are needed. METHODS: We studied the brains of patients with pathologically confirmed late-onset AD and age-mat...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Lippincott Williams & Wilkins
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4032204/ https://ncbi.nlm.nih.gov/pubmed/24719484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000417 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|